Evidence map›Paper›PMID 31726390›Full record

ArticleMolecular therapy. Nucleic acids2019

RNAm5CPred: Prediction of RNA 5-Methylcytosine Sites Based on Three Different Kinds of Nucleotide Composition.

Ting Fang, Zizheng Zhang, Rui Sun, Lin Zhu, Jingjing He, Bei Huang, Yi Xiong, Xiaolei Zhu

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Detection, molecular function and mechanisms of m5C in cancer.Clinical and translational medicine · 2025
    Review
  5. m5CStack: An integrated framework for m5C site prediction using multi-feature stacking.Computational and structural biotechnology journal · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. m6A-TSHub: Unveiling the Context-specific mGenomics, proteomics & bioinformatics · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. CNNLSTMac4CPred: A Hybrid Model for N4-Acetylcytidine Prediction.Interdisciplinary sciences, computational life sciences · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Ting FangSchool of Sciences, Anhui Agricultural University, Hefei, Anhui 230036, China; School of Life Sciences, Anhui University, Hefei, Anhui 230601, China.
Zizheng ZhangSchool of Life Sciences, Anhui University, Hefei, Anhui 230601, China.
Rui SunBeijing Baidu Netcom Sciences and Technology Co., Ltd., Beijing, China.
Lin ZhuSchool of Computer Science and Technology, Anhui University, Hefei, Anhui 230601, China.
Jingjing HeSchool of Life Sciences, Anhui University, Hefei, Anhui 230601, China.
Bei HuangSchool of Life Sciences, Anhui University, Hefei, Anhui 230601, China. Electronic address: beihuang@163.com.
Yi XiongState Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, China. Electronic address: xiongyi@sjtu.edu.cn.
Xiaolei ZhuSchool of Sciences, Anhui Agricultural University, Hefei, Anhui 230036, China; School of Life Sciences, Anhui University, Hefei, Anhui 230601, China. Electronic address: xlzhu_mdl@hotmail.com.
Anhui University · CNAnhui Agricultural University · CNBaidu (China) · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

5-methylcytosine (m5C) is one of the most common and abundant post-transcriptional modifications (PTCMs) in RNA. Recent studies showed that m5C plays important roles in many biological functions such as RNA metabolism and cell fate decision. Because most experimental methods that determine m5C sites across the transcriptome are time-consuming and expensive, it is urgent to develop accurate computational methods to identify m5C sites effectively. A benchmark dataset is important for developing and evaluating computational methods. In this work, we constructed four different datasets according to the data redundancy and imbalance. Based on these datasets, we generated three different kinds of features, i.e., KNFs (K-nucleotide frequencies), KSNPFs (K-spaced nucleotide pair frequencies), and pseDNC (pseudo-dinucleotide composition), and then used a support vector machine (SVM) to build our models. Based on the imbalanced and nonredundant dataset, Met935, we extensively studied the three kinds of features and determined an optimal combination of the features. Based on the feature combination, we built models on the three different datasets and compared them with state-of-the-art models. According to the predictive results of the stringent jackknife test, the models based on the three features, 4NF, 1SNPF, and pseDNC, are superior or comparable to other methods. To determine the best model between the models based on the imbalanced dataset Met935 and the balanced dataset Met240, we further evaluated the two models on an independent test set Test1157. Our results demonstrate that the model based on the balanced dataset Met240 achieved the highest recall (68.79%) and the highest Matthews correlation coefficient (MCC) (0.154). In addition, the model is also superior to other state-of-the-art methods according to the integrated parameter MCC on the independent test set. Thus, we selected the model based on Met240 as our final model, which was named RNAm5CPred. In addition, a web server for RNAm5CPred (http://zhulab.ahu.edu.cn/RNAm5CPred/) has been provided to facilitate experimental research.

Indexed as

5-methylcytosine sitenucleotide compositionpost-transcriptional modificationpredictionsupport vector machine

Identifiers

PMID31726390
PMCPMC6859278
OpenAlexW2980916803

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.